Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- F-1 Registration statement (foreign)
- 3.1 EX-3.1
- 3.2 EX-3.2
- 4.2 EX-4.2
- 4.3 EX-4.3
- 4.4 EX-4.4
- 4.5 EX-4.5
- 5.1 EX-5.1
- 8.3 EX-8.3
- 10.1 EX-10.1
- 10.2 EX-10.2
- 10.3 EX-10.3
- 10.4 EX-10.4
- 10.5 EX-10.5
- 10.6 EX-10.6
- 10.7 EX-10.7
- 10.8 EX-10.8
- 10.9 EX-10.9
- 10.10 EX-10.10
- 10.11 EX-10.11
- 10.12 EX-10.12
- 10.13 EX-10.13
- 21.1 EX-21.1
- 23.1 EX-23.1
- 99.1 EX-99.1
- 99.2 EX-99.2
- 99.3 EX-99.3
- 99.4 EX-99.4
- 99.5 EX-99.5
- 99.6 EX-99.6
- 99.7 EX-99.7
Associated filings
- 10 Feb 21 424B4 Prospectus supplement with pricing info
- 9 Feb 21 EFFECT Notice of effectiveness
- 5 Feb 21 F-1/A Registration statement (foreign) (amended)
- 3 Feb 21 F-1/A Registration statement (foreign) (amended)
- 1 Feb 21 F-1/A Registration statement (foreign) (amended)
-
19 Jan 21 F-1 Registration statement (foreign)
ADAG similar filings
Filing view
External links
January 19, 2021
Adagene Inc. (the “Company”)
4F, Building C14, No. 218,
Xinghu Street, Suzhou Industrial Park
Suzhou, Jiangsu Province, 25125
People’s Republic of China
Ladies and Gentlemen:
Pursuant to Rule 438 under the Securities Act of 1933, as amended, I hereby consent to the reference of my name as a director of the Company, effective immediately upon the effectiveness of the Company’s registration statement on Form F-1 initially filed by the Company on January 19, 2021 with the U.S. Securities and Exchange Commission.
Sincerely yours,
/s/ Min Li |
|
Name: Min Li |
|